The federal judge in California overseeing Allergan Inc's insider trading lawsuit against Valeant Pharmaceuticals and activist investor William Ackman has set an Aug. 20 hearing date to decide on a fast-track schedule for the case, according to court documents….
The Botox maker said in the complaint that Valeant and Ackman violated securities laws on tender offers when they teamed up on a $48 billion cash and stock offer.
Congressional Aides Can’t Abet Insider Trading, Can't Not Talk To SEC About Insider Trading
First rule of Congress is you don't talk about Congress.
Guy Convicted Of Insider Trading Still Convicted Of Insider Trading
Despite a valiant attempt at appeal.
Congress Doesn’t Understand Why SEC Is Being Such A Killjoy About This Whole Insider Trading Thing
C'mon guys, really. You don't have to do this.